Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

EASL 2021: Rapid Recap by Dr. Tarik Asselah

Source: 2021 Digital International Liver Conference*
June 23-26, 2021; Virtual
Hear a rapid update of the top HBV, HCV, and HDV studies from the Virtual 2021 International Liver Congress, 2021.
Tarik Asselah, MD, PhD
Released: July 20, 2021

Information on this Educational Activity

Faculty

Tarik Asselah, MD, PhD

Professor of Medicine
Department of Hepatology
Hôpital Beaujon
Université de Paris
Clichy, France

Tarik Asselah, MD, PhD, has disclosed that he has received consulting fees from AbbVie, Eiger, Gilead Sciences, Janssen, MYR Pharmaceuticals, and Roche.

Staff

Elaine P. Seeskin

Editorial Contributor

Elaine P. Seeskin has no relevant conflicts of interest to report.
Jennifer Blanchette, PhD

Senior Scientific Director

Jennifer M. Blanchette, PhD, has no relevant conflicts of interest to report.
Edward King, MA

Executive Vice President

Edward King, MA, has no relevant conflicts of interest to report.
Jenny Schulz, PhD

Director, Scientific Services

Jenny Schulz, PhD, has no relevant conflicts of interest to report.
Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.
Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant conflicts of interest to report.
Tina B. Stacy, PharmD, FACEHP, BCOP, CHCP

Executive Vice President, Educational Strategy
General Manager, Oncology

Tina B Stacy, PharmD, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Related Content

CCO slides on the impact of racial disparities in HCV care; key strategies on recognizing and reducing inadequate HCV care in the US and globally

Prof Ashley Brown, BSc, MD, FRCP person default Ahmed M. Elsharkawy, PhD, FRCP(UK) Oluwaseun Falade-Nwulia, MBBS, MPH Joseph K. Lim, MD Released: October 11, 2021

Clinical Care Options (CCO) video featuring Drs. Greg Dore and Stacey Trooskin discussing lessons on HCV care learned during COVID-19 lockdown

Gregory Dore, MBBS, PhD, FRACP, MPH Stacey Trooskin, MD, PhD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: October 1, 2021 Expired: September 30, 2022

Expert commentary on the utility of telemedicine visits in HCV care, from Dr. Stacey Trooskin and Clinical Care Options (CCO)

Stacey Trooskin, MD, PhD, MPH Released: September 29, 2021

Takeshi Saito, MD, PhD, discusses the limitations of current approaches to treating HDV and looks ahead to new and emerging HDV therapies, from Clinical Care Options (CCO)

Takeshi Saito, MD, PhD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: September 28, 2021 Expired: September 27, 2022
Educational grant provided by:
AbbVie
Antios Therapeutics
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue